Lacnotuzumab Antibody
Lacnotuzumab (MCS110) is a humanized anti-CSF-1 monoclonal antibody that inhibits the macrophage colony-stimulating factor pathway. It is utilized in ophthalmic research, particularly for studying retinal diseases, and has been applied in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
Anti-Human B7-H3, MCS 110, MCS110
Target
C-Fms
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
6.25 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
144.8 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog